- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 311/76 - Benzo [c] pyrannes
Détention brevets de la classe C07D 311/76
Brevets de cette classe: 143
Historique des publications depuis 10 ans
|
7
|
12
|
9
|
15
|
9
|
3
|
5
|
8
|
10
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Bristol-myers Squibb Company | 4826 |
10 |
| Autifony Therapeutics Limited | 49 |
7 |
| Sunovion Pharmaceuticals Inc. | 258 |
6 |
| PGI Drug Discovery LLC | 31 |
5 |
| Sumitomo Pharma America, Inc. | 62 |
5 |
| Biogen MA Inc. | 914 |
3 |
| Orion Corporation | 703 |
3 |
| Zhejiang Ausun Pharmaceutical Co., Ltd. | 39 |
3 |
| USA Elixiria Biotech Inc | 3 |
3 |
| CoreTerra Therapeutics, Inc. | 9 |
3 |
| International Business Machines Corporation | 61747 |
2 |
| Mayo Foundation for Medical Education and Research | 3295 |
2 |
| Beijing Shenogen Pharma Group Ltd. | 20 |
2 |
| BioMarin Pharmaceutical Inc. | 380 |
2 |
| The Hospital for Sick Children | 416 |
2 |
| The Jackson Laboratory | 358 |
2 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 168 |
2 |
| Invizyne Technologies, Inc. | 16 |
2 |
| Inventisbio LLC | 36 |
2 |
| Inventisbio Co., Ltd. | 77 |
2 |
| Autres propriétaires | 75 |